133 related articles for article (PubMed ID: 3579331)
1. [Clinical trial of a combination of human lymphoblastoid interferon (HLBI), melphalan and prednisolone (HLBI-MP) in multiple myeloma].
Hara M; Nakamura T; Fujii Y
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1338-41. PubMed ID: 3579331
[TBL] [Abstract][Full Text] [Related]
2. [Clinical trial of a combination of human lymphoblastoid interferon (HLBI) and methyl-prednisolone (HLBI-mP) in multiple myeloma].
Fukuzawa Y; Kawamura T; Ohno R
Gan To Kagaku Ryoho; 1989 Nov; 16(11):3581-6. PubMed ID: 2817909
[TBL] [Abstract][Full Text] [Related]
3. [Clinical trial of alpha-interferon (human lymphoblastoid interferon) in combination with VCAP chemotherapy in multiple myeloma].
Umeda M; Shirai T; Tsukahara T; Kaneko H; Yamauchi M; Arai N; Kosuge T; Kato M; Shikoshi K; Anno S
Rinsho Ketsueki; 1991 Jun; 32(6):669-74. PubMed ID: 1890744
[TBL] [Abstract][Full Text] [Related]
4. [Complete remission in multiple myeloma with natural interferon-alpha (HLBI) and melphalan/prednisolone intermittent therapy].
Ito M; Nakagawa T; Imoto S; Isobe T; Nakao Y
Rinsho Ketsueki; 1990 Jun; 31(6):847-52. PubMed ID: 2214176
[TBL] [Abstract][Full Text] [Related]
5. [Clinical effect of human lymphoblastoid interferon in patients with multiple myeloma].
Yoshida M; Ohta M; Muroi K; Takeda K; Kitagawa S; Tsuboyama A; Sakamoto S; Miura Y; Mutoh Y
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1394-8. PubMed ID: 6742866
[TBL] [Abstract][Full Text] [Related]
6. [Clinical effects of human lymphoblastoid interferon in patients with hematologic neoplasms].
Oda Y; Irie S; Inagaki M; Fukumoto M; Ueda I; Ohmoto E; Fujimoto S; Endo Y; Watanabe S; Lai M; Takahashi I; Kimura I; Ishii H; Sezaki T
Gan To Kagaku Ryoho; 1983 May; 10(5):1313-9. PubMed ID: 6575725
[TBL] [Abstract][Full Text] [Related]
7. The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma: phase III Eastern Cooperative Oncology Group Clinical Trial EST 9486.
Oken MM; Leong T; Lenhard RE; Greipp PR; Kay NE; Van Ness B; Keimowitz RM; Kyle RA
Cancer; 1999 Sep; 86(6):957-68. PubMed ID: 10491521
[TBL] [Abstract][Full Text] [Related]
8. [New protocols for myeloma chemotherapy plus IFN alpha].
Kitani T
Rinsho Ketsueki; 1993 Apr; 34(4):455-9. PubMed ID: 8510333
[TBL] [Abstract][Full Text] [Related]
9. Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma: results of Eastern Cooperative Oncology Group Study E2479.
Oken MM; Harrington DP; Abramson N; Kyle RA; Knospe W; Glick JH
Cancer; 1997 Apr; 79(8):1561-7. PubMed ID: 9118039
[TBL] [Abstract][Full Text] [Related]
10. [Comparative studies of intermittent melphalan and prednisolone (MP) versus 5-drug regimen (QUVMP) and 3-drug regimen (QUP) in multiple myeloma].
Hoshino S; Saito H; Wada M; Akutsu M; Shiozaki H; Takanashi M; Takei Y; Tanaka S; Teramura M; Takada K
Rinsho Ketsueki; 1987 Mar; 28(3):358-65. PubMed ID: 3475485
[No Abstract] [Full Text] [Related]
11. Human leukocyte interferon and intermittent high-dose melphalan-prednisone administration in the treatment of multiple myeloma: a randomized clinical trial from the Myeloma Group of Central Sweden.
Ahre A; Björkholm M; Mellstedt H; Brenning G; Engstedt L; Gahrton G; Gyllenhammar H; Holm G; Johansson B; Järnmark M
Cancer Treat Rep; 1984 Nov; 68(11):1331-8. PubMed ID: 6388832
[TBL] [Abstract][Full Text] [Related]
12. [Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol].
Marisavljević D; Bosković D; Radosević N; Elezović I; Tomin D; Gotić M; Antunović P
Srp Arh Celok Lek; 1996; 124(11-12):292-6. PubMed ID: 9132962
[TBL] [Abstract][Full Text] [Related]
13. Melphalan-prednisone versus alternating combination VAD/MP or VND/MP as primary therapy for multiple myeloma: final analysis of a randomized clinical study.
Cavo M; Benni M; Ronconi S; Fiacchini M; Gozzetti A; Zamagni E; Cellini C; Tosi P; Baccarani M; Tura S;
Haematologica; 2002 Sep; 87(9):934-42. PubMed ID: 12217805
[TBL] [Abstract][Full Text] [Related]
14. [Clinical study on the effect of human lymphoblastoid interferon in multiple myeloma].
Takeyama H; Yano K; Kataoka T; Yamamoto M; Emi N; Kodera Y; Kawashima K; Ohno R; Yokomaku S; Kobayashi M
Gan To Kagaku Ryoho; 1983 Sep; 10(9):2043-8. PubMed ID: 6614939
[TBL] [Abstract][Full Text] [Related]
15. [Study on the therapy of multiple myelomas--initial induction therapy (MP, IFN alpha, steroid pulse) and maintenance therapy (VMP, MP continuous, VEP, MCNU)].
Tanaka H; Kawano M; Iwato K; Asaoku H; Tanabe O; Ishikawa H; Nobuyoshi M; Sakai A; Kuramoto A
Rinsho Ketsueki; 1992 May; 33(5):655-61. PubMed ID: 1630017
[TBL] [Abstract][Full Text] [Related]
16. Alpha-2-interferon/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trial.
Cooper MR; Fefer A; Thompson J; Case DC; Kempf R; Sacher R; Neefe J; Bickers J; Scarffe JH; Spiegel R
Cancer Treat Rep; 1986 Apr; 70(4):473-6. PubMed ID: 3698041
[TBL] [Abstract][Full Text] [Related]
17. Serum beta-2-microglobulin in patients with multiple myeloma treated with alpha interferon.
Murakami H; Ogawara H; Morita K; Saitoh T; Matsushima T; Tamura J; Sawamura M; Karasawa M; Miyawaki S; Schimano S; Satoh S; Tsuchiya J
J Med; 1997; 28(5-6):311-8. PubMed ID: 9604789
[TBL] [Abstract][Full Text] [Related]
18. [Progress in the treatment of multiple myeloma].
Wada M; Mizoguchi H
Gan To Kagaku Ryoho; 1997 Jul; 24(9):1079-88. PubMed ID: 9239160
[TBL] [Abstract][Full Text] [Related]
19. [Combination chemotherapy with melphalan, cyclophosphamide, vincristine, ACNU and prednisolone (MEV(Ac)P) for multiple myeloma].
Takagi T; Oguro M; Sakai C
Rinsho Ketsueki; 1986 Dec; 27(12):2249-53. PubMed ID: 3471977
[No Abstract] [Full Text] [Related]
20. Combination chemotherapy with MCNU, vindesine, melphalan, and prednisolone (MCNU-VMP therapy) in induction therapy for multiple myeloma. Japan Myeloma Study Group.
Imamura Y; Takagi T; Yawata Y; Nishinarita S; Kosaka M; Mikuni C; Takatsuki K; Sezaki T; Mori M; Tsuchiya J
Int J Hematol; 1994 Feb; 59(2):113-23. PubMed ID: 8018904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
